MONTREAL, Sept. 27 /CNW/ -- Symbol: CXG.A-CDNX www.clemex.com Shares Outstanding: 20,749,810 MONTREAL, Sept. 27 /CNW Telbec/ - Clemex Technologies Inc. (TSX Venture CXG.a), designer and manufacturer of Image Analysis systems and software for microscopy applications, announces its results for the first quarter of FY2011 ending July 31 2010. For this first Quarter, sales reached $1,016,855, an increase of $288,224 or 39.5% compared to the same period last year. The Corporation ends this Quarter with a Net Profit of $52,816 while a Loss of $141,029 had been posted last year. Earnings for this quarter improved, after they had strongly been affected, as markets are slowly reviving from the severe economic slowdown which affected the manufacturing sector in North America. Gross Margin for this first quarter was 62.9%, similar to 63.7% for the same period last year. Over the past three months, the Company made several sales to the manufacturing sector industries such as: Evraz, Regina(SA); Evraz Rocky Mountain Steel, Pueblo (CA); Brillion Iron Works, Brillion (WI); Dana Canada Corporation, Oakville (On), and Teksid Hierro of Mexico. Important sales were also made to the pharmaceuticals sector, to Hemopharm, Serbia and Pfizer, Kalamazoo. FINANCIAL HIGHLIGHTS First Quarter (ending July 31st) ------------------------------------------------------------------------- ------------------------------------------------------------------------- Fiscal Year 2011 2010 ------------------------------------------------------------------------- $ $ Sales 1,016,855 728,631 Cost of Sales 377,322 264,847 ------------------------------------------------------------------------- Gross Margin 639,533 463,784 Operating Expenses Commercial Expenses 286,128 238,807 Administrative Expenses 171,264 169,017 R&D less Tax credits 78,434 83,884 Amortization of capital assets 30,058 28,956 Financial Expenses 21,697 22,757 Loss (gain )on foreign currency (864) 61,392 ------------------------------------------------------------------------- 586,717 604,813 Net Profit(Loss) 52,816 (141,029) Net Profit(Loss) per share 0.003 (0.007) Clement Forget, President and CEO of Clemex Technologies Inc. declared: "Results for this first quarter of FY2011 are very encouraging as we can foresee the light at the end of the tunnel with a revival of activity in our traditional sectors; the automotive and aerospace manufacturing industry. We note activity intensifies lately in our sales department as many quotes and information requests come in, the first indicator that clients are interested in purchasing new instruments. Further more, the pharmaceutical sector seems to also do better as we sold two instruments to prestigious pharmaceutical companies in the United States and in Europe". He continued, "Our order book is doing better than for the same period last year and we are confident that, unless an economic turn around occurs, the sales should continue to increase over the next few months." About Clemex Technologies, Inc. Clemex Technologies Inc. develops, manufactures and markets image analysis systems and software used by quality control and research microscopy laboratories. Clemex's customer base spans over many countries in America, Europe, Asia and encompasses major Research and Development Centers, prestigious Universities and large manufacturing industries in various fields including healthcare, automotive, aerospace, raw materials manufacturing, pharmaceuticals, mining and other sectors. The CDNX has not reviewed and does not accept responsibility for the adequacy and accuracy of this press release. Clément Forget, President and CEO, Tel: 450.651.6573, Email: ir@clemex.com

Copyright